Veru VERU
NASDAQ VERU
$2.60 -0.06 (-2.25%)
As of: Oct 1, 2026 · 10:24 AM EDT

Veru (VERU) Current Deferred Revenue (2017 - 2018)

Updated

Veru (VERU) recorded Current Deferred Revenue of $49,095 in fiscal Q1 2019 (quarter ended Dec 31, 2018), down 95.0% from $990,016 a year earlier and down 73.8% from the prior quarter.

Analysis

Veru (VERU) Current Deferred Revenue (2017 - 2018) Analysis & Trends

At the end of FY2018 (ended Sep 30, 2018), Veru reported Current Deferred Revenue of $187,159, down 81.6% from FY2017.

  • Across earlier fiscal years, Current Deferred Revenue came in at $1.01 million in FY2017.
  • On a year-over-year basis, Current Deferred Revenue has declined for three consecutive quarters.
  • Per Business Quant, the preceding three fiscal quarters came in at $187,159 (Q4 2018), $760,981 (Q3 2018) and $872,370 (Q2 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Veru 61.31 Mn -48.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 49,095.00
Sep 30, 2018 187,159.00
Jun 30, 2018 760,981.00
Mar 31, 2018 872,370.00
Dec 31, 2017 990,016.00
Sep 30, 2017 1.01 Mn
Jun 30, 2017 964,382.00
API Access

Veru Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VERU&period=max&api_key=YOUR_API_KEY